01-04-2022 | Clippings
Evaluation of daily low-dose prednisolone during upper respiratory tract infection to prevent relapse in children with relapsing steroid-sensitive nephrotic syndrome — The PREDNOS 2 randomized clinical trial (JAMA Pediatr. 2022;176:236–43)
Published in: Indian Pediatrics | Issue 4/2022
Login to get access